Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 15, Issue 20
|
pp. 11067–11091
HLA-DPA1 overexpression inhibits cancer progression, reduces resistance to cisplatin, and correlates with increased immune infiltration in lung adenocarcinoma
Back to article
Figure 4
(4 of 13)
−
100%
+
Figure 4.
The association between a decreased expression of HLA-DPA1 and poor prognosis of patients with LUAD using the LCE database.
Abbreviations: LUAD: lung adenocarcinoma; LCE: Lung Cancer Explorer.